BNB is increasingly being adopted by publicly listed companies as a strategic asset in their treasuries. Firms such as Nano Labs, Windtree Therapeutics, and Liminatus are incorporating BNB into their financial portfolios, viewing it as a significant asset beyond its traditional role as 'digital gold.' This trend highlights the growing acceptance of BNB in mainstream financial strategies.